North America Leads the Charge in Latent TB Testing: Pioneering Innovation and Future Solutions
TB is still an important problem all over the world but latent TB testing is currently known to be an effective prevention area. The region of North America particularly the United States of America and Canada has provided a model on how to embrace modern technology and policies in the elimination of LTBI. Latent TB testing has put this region among the world’s favorites because of its well-developed healthcare, and regulatory policies and strategies. In this article, the author examines how North America has adopted latent TB testing, and what its vision of the market is. According to the UnivDatos Market Insights, rising tuberculosis (TB) incidence, increased need for screening in HIV/AIDS and transplant patients, rising advanced diagnostics, and adoption of IGRAs drive the Latent TB Testing market. As per their “ Latent TB Testing Market ” report, the global market was valued at USD 1.4 Billion in 2023, growing at a CAGR of about 7.8% during the forecast period from 2024 - 203...